Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

172.61
Delayed Data
As of 4:00pm ET
 -0.53 / -0.31%
Today’s Change
133.64
Today|||52-Week Range
176.85
+18.06%
Year-to-Date
Who Could Buy Bristol-Myers Squibb?
6:25pm / MotleyFool.com - Paid Partner Content
Study Reveals PCSK9 Drugs Can Save Heart Disease Patients
Feb 21 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Amgen, Procter & Gamble, Bank of America, Netflix ...
10:02am / Zacks.com - Paid Partner Content
The Four Key Themes From Q4 Conference Calls
Feb 17 / Investing Channel - Paid Partner Content
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
8:12am / MotleyFool.com - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
7:54am / Zacks.com - Paid Partner Content
Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
Feb 17 / Zacks.com - Paid Partner Content
Top Research Reports for Amgen, Bank of America, and Proctor & Gamble
Feb 21 / Zacks.com - Paid Partner Content
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Feb 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close173.14
Today’s open172.33
Day’s range171.89 - 174.70
Volume2,579,797
Average volume (3 months)3,975,768
Market cap$127.5B
Dividend yield2.66%
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+6.49%
Earnings growth (next 5 years)+7.78%
Revenue growth (last year)+7.76%
P/E ratio17.3
Price/Sales4.80
Price/Book4.28

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.46-0.66%
BIIBBiogen+0.73+0.25%
ILMNIllumina Inc+0.15+0.09%
BIVVBioverativ Inc-0.44-0.91%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$2.99
Annual revenue (last year)$23.0B
Annual profit (last year)$7.7B
Net profit margin33.59%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs